- Home
- AVD vs FENC Comparison
AVD vs FENC Comparison
Compare AVD & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVD
- FENC
- Stock Information
- Founded
- AVD 1969
- FENC 1996
- Country
- AVD United States
- FENC United States
- Employees
- AVD N/A
- FENC N/A
- Industry
- AVD Agricultural Chemicals
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVD Industrials
- FENC Health Care
- Exchange
- AVD Nasdaq
- FENC Nasdaq
- Market Cap
- AVD 135.6M
- FENC 156.9M
- IPO Year
- AVD N/A
- FENC 2001
- Fundamental
- Price
- AVD $3.80
- FENC $5.08
- Analyst Decision
- AVD Strong Buy
- FENC Strong Buy
- Analyst Count
- AVD 1
- FENC 2
- Target Price
- AVD $14.00
- FENC $14.00
- AVG Volume (30 Days)
- AVD 237.1K
- FENC 87.7K
- Earning Date
- AVD 05-08-2025
- FENC 05-13-2025
- Dividend Yield
- AVD 0.79%
- FENC N/A
- EPS Growth
- AVD N/A
- FENC N/A
- EPS
- AVD N/A
- FENC N/A
- Revenue
- AVD $553,839,000.00
- FENC $47,538,000.00
- Revenue This Year
- AVD N/A
- FENC $2.68
- Revenue Next Year
- AVD $4.35
- FENC $71.63
- P/E Ratio
- AVD N/A
- FENC N/A
- Revenue Growth
- AVD N/A
- FENC 123.69
- 52 Week Low
- AVD $3.28
- FENC $3.96
- 52 Week High
- AVD $12.67
- FENC $10.07
- Technical
- Relative Strength Index (RSI)
- AVD 39.63
- FENC 34.36
- Support Level
- AVD $3.28
- FENC $5.02
- Resistance Level
- AVD $4.74
- FENC $5.50
- Average True Range (ATR)
- AVD 0.26
- FENC 0.41
- MACD
- AVD 0.02
- FENC -0.03
- Stochastic Oscillator
- AVD 41.60
- FENC 22.22
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.